Cargando…
Aberrant activation of NF-κB signaling in mammary epithelium leads to abnormal growth and ductal carcinoma in situ
BACKGROUND: Approximately 1 in 5 women diagnosed with breast cancer are considered to have in situ disease, most often termed ductal carcinoma in situ (DCIS). Though recognized as a risk factor for the development of more invasive cancer, it remains unclear what factors contribute to DCIS developmen...
Autores principales: | Barham, Whitney, Chen, Lianyi, Tikhomirov, Oleg, Onishko, Halina, Gleaves, Linda, Stricker, Thomas P., Blackwell, Timothy S., Yull, Fiona E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4590702/ https://www.ncbi.nlm.nih.gov/pubmed/26424146 http://dx.doi.org/10.1186/s12885-015-1652-8 |
Ejemplares similares
-
Inhibition of NF-kappaB activity in mammary epithelium increases tumor latency and decreases tumor burden
por: Connelly, Linda, et al.
Publicado: (2010) -
NF-kappaB activation within macrophages leads to an anti-tumor phenotype in a mammary tumor lung metastasis model
por: Connelly, Linda, et al.
Publicado: (2011) -
Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model
por: Wilson, Andrew J, et al.
Publicado: (2013) -
Manipulating the NF-κB pathway in macrophages using mannosylated, siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions
por: Ortega, Ryan A, et al.
Publicado: (2016) -
Ductal barriers in mammary epithelium
por: Owens, Mark B, et al.
Publicado: (2013)